Stockscreener 앱 받기
41.18
0.68%
0.28
Axogen Inc 주식(AXGN)의 최신 뉴스
Precision Trading with Axogen Inc. (AXGN) Risk Zones - Stock Traders Daily
Which Is a Better Investment, Axogen, Inc. or Omnicell, Inc. Stock? - AAII
Stephens Investment Management Group LLC Acquires New Stake in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) price target increased by 16.82% to 51.71 - MSN
Bessemer Group Inc. Sells 345,347 Shares of AxoGen, Inc. $AXGN - MarketBeat
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam - Yahoo Finance
AxoGen, Inc. $AXGN Shares Purchased by Vanguard Group Inc. - MarketBeat
HighMark Wealth Management LLC Acquires 158,855 Shares of AxoGen, Inc. $AXGN - MarketBeat
Axogen director sells shares after option exercise | AXGN Insider Trading - Stock Titan
Technical Reactions to AXGN Trends in Macro Strategies - Stock Traders Daily
Insider Sell Alert: Jens Kemp Sells 4,000 Shares of Axogen Inc (AXGN) - GuruFocus
Axogen CMO Jens Kemp sells $173,761 in company stock By Investing.com - Investing.com Nigeria
Axogen CFO Lindsey Hartley sells $45,897 in AXGN stock By Investing.com - Investing.com Nigeria
Axogen CFO Lindsey Hartley sells $45,897 in AXGN stock - Investing.com UK
[144] Axogen, Inc. SEC Filing - Stock Titan
Axogen (AXGN) director exercises options and sells 11,050 common shares - Stock Titan
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Axogen (AXGN) CMO sells 4,000 shares around $43 per share - Stock Titan
Axogen (NASDAQ: AXGN) CFO nets shares after option exercises and sales - Stock Titan
Axogen (AXGN) Sales VP sells 3,878 shares, retains 92,416 - Stock Titan
Axogen (NASDAQ: AXGN) VP Quackenbush discloses initial equity holdings - Stock Titan
AxoGen, Inc. (AXGN) Stock Analysis: 17% Upside Potential Amid Robust Revenue Growth - DirectorsTalk Interviews
Axogen Director Sold Shares Worth Over $720K - TradingView
AXGN (NASDAQ) Form 144 lists 3,878 shares via Morgan Stanley broker - Stock Titan
First Light, Mathew Arens report 3.62M Axogen holdings (AXGN) - Stock Titan
How many employees work at AxoGen? - Revelio Labs
Number of shareholders of Axogen, Inc. – NASDAQ:AXGN - TradingView
Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition - MSN
Canaccord Genuity Sticks to Its Buy Rating for AxoGen (AXGN) - The Globe and Mail
Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed? - simplywall.st
Axogen (AXGN) Q1 2025 Earnings Transcript - AOL.com
AxoGen (NASDAQ:AXGN) Cut to "Hold" at Wall Street Zen - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Axogen (AXGN) Q1 2026 Deep Dive: $0.07 EPS, Revenue Up 27% - AlphaStreet
Nerve Repair And Regenerative Market Set to Boom Rapidly, - openPR.com
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference - The Manila Times
Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78 - simplywall.st
AxoGen Reports Third Quarter 2025 Financial Results and Growth - HarianBasis.co
AXGN SEC FilingsAxogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
AXGN Maintained by Canaccord Genuity -- Price Target Raised to $50 - GuruFocus
Vanguard reports 2.66M Axogen stake (NASDAQ: AXGN) - Stock Titan
[ARS] Axogen, Inc. SEC Filing - Stock Titan
FDA win and 20% growth frame Axogen (NASDAQ: AXGN) 2026 pay vote - Stock Titan
AXGN Maintained by Citizens -- Price Target Raised to $50.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
0.32%
0.17%
자본화:
|
볼륨(24시간):